What is Pairwise?
Pairwise operates at the intersection of biotechnology and food security, utilizing advanced CRISPR tools to enhance crop resilience, nutritional profiles, and overall yield. By focusing on climate-adaptive traits and consumer-centric produce, the company aims to disrupt traditional, resource-intensive agricultural supply chains. Their market position is defined by a commitment to sustainable, plant-based alternatives that address the growing global demand for efficient and healthy food production. Through its sophisticated R&D pipeline, Pairwise is effectively bridging the gap between laboratory-scale genetic innovation and practical, field-ready agricultural solutions.
How much funding has Pairwise raised?
Pairwise has raised a total of $155M across 3 funding rounds:
Series A
$25M
Series B
$90M
Series C
$40M
Series A (2018): $25M with participation from Monsanto Growth Ventures and Deerfield
Series B (2021): $90M led by Temasek, Leaps by Bayer, Deerfield, and Pontifax AgTech Management
Series C (2024): $40M supported by Aliment Capital, Deerfield, and Corteva Agriscience
Key Investors in Pairwise
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare and life sciences through flexible funding models and deep market intelligence.
Temasek
Temasek is a global investment company headquartered in Singapore that acts as a generational investor with a long-term focus on sustainable growth.
Aliment Capital
Aliment Capital is a specialized growth capital investor dedicated to food and agriculture technology, focusing on productivity, nutrition, and supply chain efficiency.
What's next for Pairwise?
With the infusion of this latest capital, Pairwise is well-positioned to accelerate its commercialization strategy and expand its footprint in the global food market. The company is expected to prioritize the scaling of its gene-edited produce lines, focusing on operational efficiency and supply chain integration. As the firm moves into this mature growth phase, strategic efforts will likely center on regulatory navigation, market penetration for its flagship products, and the continued refinement of its CRISPR-based breeding platform to meet evolving climate challenges. This funding provides the necessary runway to solidify its status as a cornerstone of the next generation of agricultural technology.
See full Pairwise company page
